ArticleInvestigational new drugs2020

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors.

Toshihiko Doi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.